Table 4.
Antibiotic | 2011/2013 N (%S) | 2015/2016 N (%S) | OR (95% CI) | P |
---|---|---|---|---|
Ampicillin | 784 (81%) | 596 (85%) | 1.34 (1.00–1.79) | 0.06 |
Ceftriaxone | 690 (97%) | 655 (97%) | 0.99 (0.53–1.87) | 1 |
Ciprofloxacin | 877 (95%) | 721 (90%) | 0.48 (0.32–0.70) | 0.0001 |
Trimethoprim/sulfamethoxazole | 877 (92%) | 721 (71%) | 0.21 (0.16–0.28) | 0.0001 |
KEY = CI confidence interval, N Number of isolates tested in each bacteria/antibiotic combination, OR Odds Ratio, S Susceptibility, % percent
P < 0.05 is considered statistically significant
aThe 2011/2013 data are taken from: Chamoun K, Farah M, Araj G, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016;46:64–70